NCT07166913

Brief Summary

The purpose of this study is to examine the implementation and effectiveness of a bundle of engagement strategies for pediatric patient centered outcomes research (PCOR) studies. The study aims to examine the effectiveness of a "bundle" of enhanced engagement strategies on improved stakeholder engagement and study protocol indicators (including improved language access, meeting recruitment/retention goals) compared to standard practice.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
480

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Sep 2025Dec 2026

Study Start

First participant enrolled

September 8, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

September 9, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 11, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

September 16, 2025

Status Verified

September 1, 2025

Enrollment Period

1.2 years

First QC Date

September 9, 2025

Last Update Submit

September 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Research Engagement Survey Tool (REST) stakeholder engagement score

    This tool consists of 32 items and assesses engagement across 8 domains, using a 5-point Likert scale for each item. The 8 domains include: 1) focus on community perspectives and determinants of health, 2) partner input, 3) partnership sustainability, 4) fostering co-learning, capacity building and co-benefit, 5) building on strengths and resources, 6) facilitating collaborative, equitable partnerships, 7) involving partners in the dissemination process, and 8) building and maintaining trust. Engagement principle (EP) scores are calculated as an average of non-missing items. The 8 means are used to calculate the overall stakeholder engagement score. Higher scores indicate higher degree of stakeholder engagement.

    Month 6

Secondary Outcomes (3)

  • Patient Engagement in Research Scale (PEIRS) stakeholder engagement score

    Month 6

  • Reading grade level of written materials

    Month 6

  • Patient Education Materials Assessment Tool (PEMAT) score

    Month 6

Study Arms (2)

Enhanced Strategies

EXPERIMENTAL

Subjects assigned to the Enhanced Strategies arm will receive a toolkit of enhanced stakeholder engagement strategies.

Behavioral: Toolkit

Standard Practice

NO INTERVENTION

No Intervention. Participants will continue to implement standard practices used by investigator

Interventions

ToolkitBEHAVIORAL

The toolkit contains information regarding enhanced stakeholder engagement strategies. The toolkit includes guidance materials, checklists, and templates/ sample materials, to increase stakeholder engagement in the research. This includes guidance on setting up a stakeholder advisory board (SAB) and ensuring literacy- and language- sensitivity of participant-/stakeholder-facing materials.

Enhanced Strategies

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • In order to be eligible to participate in this study, PIs must oversee a study that meets the following criteria:
  • Studies who either have not started enrollment or are within 1-3 months of the start of enrollment, and within the 25% ceiling for % recruitment target.
  • Studies that have started enrollment must be no further than 25% of projected enrollment timeline of the study (with at least 6 months remaining for enrollment).
  • Target n\>50 participants in study.
  • At least 10 stakeholder partners part of study. The PI's must also be ≥18 years old;
  • In order for study stakeholders to be eligible to participate in this study, an individual must meet all of the following criteria:
  • \>=12 years old;
  • Ability to speak either English, Spanish, or Chinese, and;
  • Part of the study team or serving in an advisory capacity to the study team
  • The same criteria as that used for stakeholder and PI eligibility applies to Key informant (KI) interviews.

You may not qualify if:

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • Not able to complete 6 month follow-up assessment
  • Children who are wards/foster children
  • Not able or willing to provide consent.
  • Concurrent enrollment in another study that is part of this research project.
  • In addition, PI's who meet the following criteria will be excluded from participation in this study:
  • \. A lot of experience with stakeholder engagement (based on screener survey question)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

RECRUITING

Study Officials

  • H. Shonna Yin, MD, MS

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

H. Shonna Yin, MD, MS

CONTACT

Jessica Velazquez-Perez

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2025

First Posted

September 11, 2025

Study Start

September 8, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

September 16, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

The de-identified participant data from the final research dataset will be shared upon reasonable request beginning 9 to 36 months after publication or as required by a condition of awards or supporting agreements, provided the requesting investigator executes a data use agreement with NYU Langone Health. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's Data Sharing Strategy Board (DSSB). Requests should be directed to: Hsiang.Yin@nyulangone.org. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access Criteria
The investigator who proposed to use the data will be granted access upon reasonable request. Requests should be directed to Hsiang.Yin@nyulangone.org. To gain access, data requestors will need to sign a data access agreement. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's DSSB.

Locations